An elevated HScore is associated with poor clinical outcomes in COVID-19

Benavente, Rafael; Peña, Camila; Cid, Allyson; Cabello, Nicolás; Bustamante, Pablo; Álvarez, Marco; Henríquez, Elizabeth; Soto, Andrés; Rubilar, Erika.
Rev. méd. Chile ; 151(1): 15-22, feb. 2023. tab
Artigo em Inglês | LILACS | ID: biblio-1515413

Documentos relacionados

  1. An elevated HScore is associated with poor clinical outcomes in COVID-19.
  2. [Hemophagocytic syndrome secondary to COVID-19: a case report and literature review].
  3. Common bone marrow signature in COVID-19-associated multisystem inflammatory syndrome in children: A first-wave small case series experience.
  4. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
  5. Association of a decreased platelet count with poor survival in patients with adult secondary hemophagocytic lymphohistiocytosis.
  6. Secondary hemophagocytic lymphohystiocytosis in a Rubinstein Taybi syndrome patient.
  7. Infection-associated Hemophagocytic Syndrome in Critically Ill Patients with COVID-19.
  8. Hepatic haemophagocytosis in haematology patients with hepatic dysfunction: prognostic impact and contribution of liver biopsy combined with the haemophagocytic syndrome diagnostic score (HScore).
  9. Non-osteopenic Bone Pathology After Allo-hematopoietic Stem Cell Transplantation in Patients with Inborn Errors of Immunity.
  10. A Case of Hemophagocytic Lymphohistiocytosis following Second Dose of COVID-19 Vaccination.